Skip to Content


National Center for Injury Prevention and Control/Initial Review Group, (NCIPC/IRG)

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Correction: This notice was published in the Federal Register on February 18, 2010, Volume 75, Number 32, page 7281. The notice should read as follows:

NCIPC/IRG Workgroup: Unintentional Poisoning from Prescription Drug Overdoses in Adults (R21), Funding Opportunity Announcement CE10-002.

In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned review group:

Time and Date: 12:30 p.m.-4 p.m., March 3, 2010 (Closed).

Place: Teleconference.

Status: This meeting was closed to the public in accordance with provisions set forth in 41 CFR part 102 of the General Services Administration Federal Advisory Committee Management Final Rule.

Matters to be Discussed: The meeting included the review, discussion, and evaluation of applications intended for the prevention of unintentional poisonings from drug overdoses in the adult population. Requests for Applications are related to the following individual research announcement: CE10-002.

Agenda items are subject to change as priorities dictate.

For Further Information Contact: J. Felix Rogers, PhD, M.P.H., NCIPC/ERPO, CDC, 4770 Buford Highway, NE., M/S F63, Atlanta, Georgia 30341-3724, Telephone (770) 488-4334.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Start Signature

Dated: June 8, 2010.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. 2010-14633 Filed 6-16-10; 8:45 am]